These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23075446)

  • 1. Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.
    Trilling M; Le VT; Hengel H
    Future Microbiol; 2012 Nov; 7(11):1269-82. PubMed ID: 23075446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cell types in cytomegalovirus infection in vivo.
    Sacher T; Mohr CA; Weyn A; Schlichting C; Koszinowski UH; Ruzsics Z
    Eur J Cell Biol; 2012 Jan; 91(1):70-7. PubMed ID: 21492952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system.
    Mocarski ES
    Cell Microbiol; 2004 Aug; 6(8):707-17. PubMed ID: 15236638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicide watch: how cytomegalovirus interferes with the cell-death pathways of infected cells.
    Andoniou CE
    Tissue Antigens; 2010 Jul; 76(1):1-8. PubMed ID: 20403148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifaceted evasion of the interferon response by cytomegalovirus.
    Marshall EE; Geballe AP
    J Interferon Cytokine Res; 2009 Sep; 29(9):609-19. PubMed ID: 19708810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.
    Saffert RT; Kalejta RF
    J Virol; 2007 Sep; 81(17):9109-20. PubMed ID: 17596307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the innate immune response by human cytomegalovirus.
    Biolatti M; Gugliesi F; Dell'Oste V; Landolfo S
    Infect Genet Evol; 2018 Oct; 64():105-114. PubMed ID: 29935337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
    Dutia BM; Allen DJ; Dyson H; Nash AA
    Virology; 1999 Sep; 261(2):173-9. PubMed ID: 10497103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.
    Le-Trilling VT; Trilling M
    Tissue Antigens; 2015 Jul; 86(1):1-13. PubMed ID: 26061653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeling manipulated: cytomegalovirus immune manipulation.
    Miller-Kittrell M; Sparer TE
    Virol J; 2009 Jan; 6():4. PubMed ID: 19134204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
    Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S
    PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness.
    Souquette A; Frere J; Smithey M; Sauce D; Thomas PG
    Geroscience; 2017 Jun; 39(3):293-303. PubMed ID: 28647907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-distance interferon signaling within the brain blocks virus spread.
    van den Pol AN; Ding S; Robek MD
    J Virol; 2014 Apr; 88(7):3695-704. PubMed ID: 24429359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.
    Sissons JG; Wills MR
    Med Microbiol Immunol; 2015 Jun; 204(3):307-16. PubMed ID: 25896527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus.
    Banks TA; Rickert S; Ware CF
    Immunol Res; 2006; 34(3):243-54. PubMed ID: 16891674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match.
    Webb JR; Lee SH; Vidal SM
    Genes Immun; 2002 Aug; 3(5):250-62. PubMed ID: 12140743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.
    Loewendorf A; Benedict CA
    J Intern Med; 2010 May; 267(5):483-501. PubMed ID: 20433576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.